Free Trial

Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Linden Thomas Advisory Services LLC

Intuitive Surgical logo with Medical background

Linden Thomas Advisory Services LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,217 shares of the medical equipment provider's stock after purchasing an additional 562 shares during the period. Intuitive Surgical comprises approximately 0.7% of Linden Thomas Advisory Services LLC's portfolio, making the stock its 16th largest position. Linden Thomas Advisory Services LLC's holdings in Intuitive Surgical were worth $5,333,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of ISRG. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $26,000. Godsey & Gibb Inc. boosted its stake in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after acquiring an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth about $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical in the 3rd quarter valued at about $38,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have commented on ISRG. Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Tuesday, November 19th. Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. BTIG Research raised their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a research report on Tuesday, November 26th. Finally, Robert W. Baird upped their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average target price of $583.83.

Get Our Latest Stock Analysis on ISRG

Intuitive Surgical Trading Down 4.0 %

Shares of ISRG stock traded down $24.61 during mid-day trading on Friday, reaching $584.05. The stock had a trading volume of 4,350,539 shares, compared to its average volume of 1,342,626. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The business has a 50-day simple moving average of $547.16 and a 200 day simple moving average of $504.35. The company has a market cap of $208.03 billion, a P/E ratio of 93.90, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Insider Buying and Selling at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 18,151 shares of the company's stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now owns 8,757 shares of the company's stock, valued at approximately $4,727,816.73. This represents a 2.98 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 42,475 shares of company stock valued at $22,070,807 over the last quarter. Corporate insiders own 0.90% of the company's stock.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Pelosi Bets Big on AI: Her Top 5 Stock Picks
Risk vs. Reward: Why Analysts Predict Big Gains for Struggling SMCI
3 Quantum Computing Stocks to Watch in 2025 (That Aren’t Rigetti)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines